Afya Ltd
NASDAQ:AFYA

Watchlist Manager
Afya Ltd Logo
Afya Ltd
NASDAQ:AFYA
Watchlist
Price: 17.93 USD 0.34% Market Closed
Market Cap: 1.6B USD

Afya Ltd
Investor Relations

Afya Ltd. is an intriguing player in the education and healthcare sectors of Brazil, carving its niche in the market by providing educational services to medical students and professionals. Founded in 2017, the company's journey began with a mission to tackle the chronic shortage of qualified healthcare professionals in the country. Through a series of strategic acquisitions, Afya rapidly expanded its portfolio of medical schools and associated educational programs, becoming the preeminent provider of medical courses in Brazil. The company's growth is anchored in its distinctive hybrid business model that blends traditional brick-and-mortar educational institutions with a dynamic digital learning platform, thereby ensuring comprehensive learning experiences for aspiring medical professionals.

Revenue generation for Afya rests on its ability to enroll students into its extensive array of undergraduate and graduate medical programs, as well as continuing education courses that are mandated for medical professionals in Brazil. By leveraging economies of scale, Afya manages to run these programs efficiently, resulting in robust financial performance. The company makes money primarily through tuition fees, which are supplemented by its digital offerings, catering to a broader array of healthcare education needs. Through its digital platform, Afya not only enhances accessibility to its educational content but also taps into the growing demand for online learning solutions. This dual-channel approach enables Afya to remain agile in a rapidly evolving educational landscape while reinforcing its commitment to improving Brazil's healthcare by shaping the next generation of medical professionals.

Show more
Loading

Earnings Calls

2024 Q4
Feb 26, 2025
Show Transcript
Previous
Next
Solid growth and optimism in fragrance market drive confidence for 2025.
2024 Q4
Feb 26, 2025

Interparfums had a strong finish in 2024, achieving $1.452 billion in sales, a 10% increase. They are optimistic about the upcoming year, projecting a 4% growth to $1.51 billion in 2025, with EBITDA of $5.35 per share. Key brands like GUESS and Ferragamo, along with new launches, are expected to drive growth. The company plans significant marketing investments, expecting higher A&P spending early in 2025. Despite FX challenges and increased competition, they remain committed to maintaining margins and delivering strong results.

Show Full Analysis

Management

Mr. Virgilio Deloy Capobianco Gibbon
Chief Executive Officer
No Bio Available
Mr. Luis Andre Carpintero Blanco
Chief Financial Officer
No Bio Available
Renata Couto
Investor Relations Executive Manager
No Bio Available
Mr. Julio Eduardo Razente de Angeli
Vice President of Continuing Education & Innovation
No Bio Available

Contacts

Address
MINAS GERAIS
Nova Lima
Alameda Oscar Niemeyer, No 119, Sala 504 Vila Da Serra
Contacts
+553135157500.0
afya.com.br